1.Minimally Invasive Surgery in Thymic Malignances.
Wentao FANG ; Zhitao GU ; Keneng CHEN ; Members of the Chinese Alliance for Research in Thymomas
Chinese Journal of Lung Cancer 2018;21(4):269-272
Surgery is the most important therapy for thymic malignances. The last decade has seen increasing adoption of minimally invasive surgery (MIS) for thymectomy. MIS for early stage thymoma patients has been shown to yield similar oncological results while being helpful in minimize surgical trauma, improving postoperative recovery, and reduce incisional pain. Meanwhile, With the advance in surgical techniques, the patients with locally advanced thymic tumors, preoperative induction therapies or recurrent diseases, may also benefit from MIS in selected cases.
Humans
;
Minimally Invasive Surgical Procedures
;
methods
;
trends
;
Retrospective Studies
;
Thymoma
;
surgery
;
Thymus Neoplasms
;
mortality
;
pathology
;
surgery
2.Predictors of Recurrence after Thymoma Resection.
Mi Kyung BAE ; Chang Young LEE ; Jin Gu LEE ; In Kyu PARK ; Dae Joon KIM ; Woo Ick YANG ; Kyung Young CHUNG
Yonsei Medical Journal 2013;54(4):875-882
PURPOSE: Recurrence rate is considered a better measure of clinical outcomes after thymoma resection than overall survival due to the indolent behavior of thymomas. This study was designed to determine predictors of recurrence after thymoma resection. MATERIALS AND METHODS: A single-institution, retrospective study was performed, including 305 patients who had undergone thymoma resection between 1986 and 2009. RESULTS: Among 305 patients, recurrence was observed in 41 patients (13.4%). The recurrence rates were 0% (0/19), 6.3% (4/63), 4.2% (2/48), 18.6% (11/59) and 20.7% (24/116) for type A, AB, B1, B2 and B3 tumors, respectively. The recurrence rate according to Masaoka stage was 6.1% (8/132), 11.4% (13/114), 26.8% (11/41) and 50.0% (9/18) for stages I, II, III and IV, respectively. After univariate analysis, completeness of resection (R0 versus R1), World Health Organization (WHO) histologic type (A, AB, B1 versus B2, B3), Masaoka stage, and size of tumor (<8 cm versus > or =8 cm) demonstrated significant differences with freedom from recurrence. Upon multivariate analysis, Masaoka stage was the only independent predictor of recurrence. CONCLUSION: WHO histologic type, Masaoka stage, and size of tumor were associated with recurrence. Particularly, Masaoka stage was the only independent predictor of recurrence after thymoma resection.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Recurrence, Local/epidemiology/*etiology
;
Retrospective Studies
;
Thymoma/mortality/*pathology/*surgery
;
Thymus Neoplasms/mortality/*pathology/*surgery
;
Young Adult
3.Long-term prognostic analysis of thymectomized patients with myasthenia gravis.
Wei LIU ; Ti TONG ; Zhendong JI ; Zhenhe ZHANG
Chinese Medical Journal 2002;115(2):235-237
OBJECTIVETo study the factors affecting the long-term prognosis of patients with myasthenia gravis (MG) after thymectomy.
METHODS170 MG patients who had undergone thymectomies were studied retrospectively. Among them, 124 patients received long-term follow-up for more than 40 months postoperatively. The COX regression analysis model was used to analyze the factors that may influence the long-term prognosis. These factors included thymus pathology, patient gender, age, duration of disease at the time of surgery, preoperative Osserman classification and medication.
RESULTSThe research showed that thymus pathology was the single independent factor that affected the postoperative long-term prognosis. The long-term survival rates differed significantly with thymus pathological types: hyperplasia > benign thymoma > atrophy > malignant thymoma (P < 0.05).
CONCLUSIONThe different pathological types of the thymus were the important factor affecting long-term survival in MG patients after thymectomy.
Adolescent ; Adult ; Aged ; Atrophy ; etiology ; Child ; Child, Preschool ; Female ; Humans ; Hyperplasia ; etiology ; Male ; Middle Aged ; Myasthenia Gravis ; mortality ; surgery ; Postoperative Complications ; Prognosis ; Survival Analysis ; Survival Rate ; Thymectomy ; adverse effects ; Thymoma ; etiology ; Thymus Gland ; pathology ; surgery ; Time Factors